10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Isolation, culture and detection of mesenchymal stem cells in tissues from critical limb ischemia model in rat

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Rat mesenchymal stem cells (MSCs) represent a small portion of the cells in the stromal compartment of bone marrow and have the potential to differentiate into new blood vessel and other tissues.

          MSCs transplantation in tissues from critical limb ischemia model in rat may represent a therapeutic applications of vascular regeneration.

          Aim

          The aim of this study was to isolate with a simple method the rat bone marrow stromal cells. Then the adherent cells were labeled with 5-bromo-2-deoxyuridine (BrdU, Sigma) and injected in the gastrocnemius and adductor muscle of ischemic hind limbs in order to demonstrate their presence in the critical limb ischemia model in rat.

          Material and methods

          MSCs were isolated from Wistar rats, 8 weeks of age. The MSCs were labeled in vitro for later identification by adding 10 μg/mL 5-bromo-2 –deoxyuridine (BrdU, Sigma).

          Results

          Small colonies of fibroblast-like cells were seen after several days of primary culture. These colonies increased in size and were subcultured after 15–18 days.

          Conclusion

          The MSCs obtained in this study presented a stable undifferentiated phenotype under normal culture conditions.

          MSCs are easy to isolate, culture, and detect in in vivo culture. These cells are characterized by high plasticity and could have an important role in angiogenesis.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

          Mesenchymal stem cells (MSCs) are a prototypical adult stem cell with capacity for self-renewal and differentiation with a broad tissue distribution. Initially described in bone marrow, MSCs have the capacity to differentiate into mesoderm- and nonmesoderm-derived tissues. The endogenous role for MSCs is maintenance of stem cell niches (classically the hematopoietic), and as such, MSCs participate in organ homeostasis, wound healing, and successful aging. From a therapeutic perspective, and facilitated by the ease of preparation and immunologic privilege, MSCs are emerging as an extremely promising therapeutic agent for tissue regeneration. Studies in animal models of myocardial infarction have demonstrated the ability of transplanted MSCs to engraft and differentiate into cardiomyocytes and vasculature cells, recruit endogenous cardiac stem cells, and secrete a wide array of paracrine factors. Together, these properties can be harnessed to both prevent and reverse remodeling in the ischemically injured ventricle. In proof-of-concept and phase I clinical trials, MSC therapy improved left ventricular function, induced reverse remodeling, and decreased scar size. This article reviews the current understanding of MSC biology, mechanism of action in cardiac repair, translational findings, and early clinical trial data of MSC therapy for cardiac disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human mesenchymal stem cells: from basic biology to clinical applications.

            Mesenchymal stem cells (MSC) are a group of clonogenic cells present among the bone marrow stroma and capable of multilineage differentiation into mesoderm-type cells such as osteoblasts, adipocytes and chondrocytes. Due to their ease of isolation and their differentiation potential, MSC are being introduced into clinical medicine in variety of applications and through different ways of administration. Here, we discuss approaches for isolation, characterization and directing differentiation of human mesenchymal stem cells (hMSC). An update of the current clinical use of the cells is also provided.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences

              Abstract Tumour-associated fibroblasts (TAFs) are part of the tumour stroma, providing functional and structural support for tumour progression and development. The origin and biology of TAFs are poorly understood, but within the tumour environment, TAFs become activated and secrete different paracrine and autocrine factors involved in tumorigenesis. It has been shown that bone marrow mesenchymal stem cells (MSCs) can be recruited into the tumours, where they proliferate and acquire a TAF-like phenotype. We attempted to determine to what extent TAFs characteristics in vitro juxtapose to MSCs’ definition, and we showed that TAFs and MSCs share immunophenotypic similarities, including the presence of certain cell surface molecules [human leukocyte antigen-DR subregion (HLA-DR), CD29, CD44, CD73, CD90, CD106 and CD117]; the expression of cytoskeleton and extracellular matrix proteins, such as vimentin, α-smooth muscle actin, nestin and trilineage differentiation potential (to adipocytes, chondrocytes and osteoblasts). When compared to MSCs, production of cytokines, chemokines and growth factors showed a significant increase in TAFs for vascular endothelial growth factor, transforming growth factor-β1, interleukins (IL-4, IL-10) and tumour necrosis factor α. Proliferation rate was highly increased in TAFs and fibroblast cell lines used in our study, compared to MSCs, whereas ultrastructural details differentiated the two cell types by the presence of cytoplasmic elongations, lamellar content lysosomes and intermediate filaments. Our results provide supportive evidence to the fact that TAFs derive from MSCs and could be a subset of ‘specialized’ MSCs.
                Bookmark

                Author and article information

                Journal
                Clujul Med
                Clujul Med
                CM
                Clujul Medical
                Iuliu Hatieganu University of Medicine and Pharmacy
                1222-2119
                2066-8872
                2013
                04 February 2013
                : 86
                : 1
                : 65-68
                Affiliations
                [1 ]Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania 2 nd Surgical Clinic, Cluj-Napoca, Romania
                [2 ]Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania
                Author notes
                Adress for correspondence: ovidiugrad@ 123456gmail.com
                Article
                cm-86-65
                4462486
                35a32d93-995a-4495-b99b-dcd5576dbf3a
                Copyright @ 2013

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

                History
                : 31 December 2012
                : 18 January 2013
                : 24 January 2013
                Categories
                Original Research
                Surgery

                mesenchymal stem cells,critical limb ischemia model in rat,angiogenesis

                Comments

                Comment on this article